Brief: CytRx CEO cautiously optimistic about FDA's pending decision on lifting partial clinical hold on trials

LadRx

06/01/2015 18:39

Jan 6 (Reuters) - CytRx Corp  CYTR.O : 
 * CEO says cautiously optimistic about FDA's pending decision on lifting 
   partial clinical hold on trials of its cancer drug aldoxorubicin 
 * CEO says company expects to hear back from FDA on lifting partial clinical 
   hold on trials later in January 
 * CEO says if partial clinical hold is lifted, company expects to launch 
   aldoxorubicin to treat soft tissue sarcoma in 2017 
  
 
 ((Bengaluru Newsroom; +1 646 223 8780))